NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...

Qure.ai aims to capture more market share globally, including the US, by next year. Lung cancer is the leading cause of cancer death worldwide, accounting for about 2.4 million patients diagnosed and ...

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

CAT scans detecting cancer is nothing new. But now, doctors are using artificial intelligence to spot cancer even sooner.“I'm here three years later because I did find out and because I did finally ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

FREMONT, Calif., January 13, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and ...

Solstice, a Singapore lung cancer study, uses LDCT scans to detect early-stage lung cancer in at-risk individuals, including non-smokers with a family history. The study found cancerous nodules in ...